345 related articles for article (PubMed ID: 9239422)
1. E2 transacylase-deficient (type II) maple syrup urine disease. Aberrant splicing of E2 mRNA caused by internal intronic deletions and association with thiamine-responsive phenotype.
Chuang JL; Cox RP; Chuang DT
J Clin Invest; 1997 Aug; 100(3):736-44. PubMed ID: 9239422
[TBL] [Abstract][Full Text] [Related]
2. Maple syrup urine disease: domain structure, mutations and exon skipping in the dihydrolipoyl transacylase (E2) component of the branched-chain alpha-keto acid dehydrogenase complex.
Chuang DT; Fisher CW; Lau KS; Griffin TA; Wynn RM; Cox RP
Mol Biol Med; 1991 Feb; 8(1):49-63. PubMed ID: 1943690
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
[TBL] [Abstract][Full Text] [Related]
4. Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.
Mitsubuchi H; Nobukuni Y; Akaboshi I; Indo Y; Endo F; Matsuda I
J Clin Invest; 1991 Apr; 87(4):1207-11. PubMed ID: 2010537
[TBL] [Abstract][Full Text] [Related]
5. Occurrence of a 2-bp (AT) deletion allele and a nonsense (G-to-T) mutant allele at the E2 (DBT) locus of six patients with maple syrup urine disease: multiple-exon skipping as a secondary effect of the mutations.
Fisher CW; Fisher CR; Chuang JL; Lau KS; Chuang DT; Cox RP
Am J Hum Genet; 1993 Feb; 52(2):414-24. PubMed ID: 8430702
[TBL] [Abstract][Full Text] [Related]
6. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Yoshioka A; Matsuda I
J Clin Invest; 1991 May; 87(5):1862-6. PubMed ID: 2022752
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of the E1 beta subunit in the branched-chain alpha-keto acid dehydrogenase complex due to a single base substitution of the intron 5, resulting in two alternatively spliced mRNAs in a patient with maple syrup urine disease.
Hayashida Y; Mitsubuchi H; Indo Y; Ohta K; Endo F; Wada Y; Matsuda I
Biochim Biophys Acta; 1994 Feb; 1225(3):317-25. PubMed ID: 8312380
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of mutations in maple syrup urine disease (MSUD): screening and identification of affected E1 alpha and E1 beta subunits of the branched-chain alpha-keto-acid dehydrogenase multienzyme complex.
Nobukuni Y; Mitsubuchi H; Hayashida Y; Ohta K; Indo Y; Ichiba Y; Endo F; Matsuda I
Biochim Biophys Acta; 1993 Nov; 1225(1):64-70. PubMed ID: 8161368
[TBL] [Abstract][Full Text] [Related]
9. A 17-bp insertion and a Phe215----Cys missense mutation in the dihydrolipoyl transacylase (E2) mRNA from a thiamine-responsive maple syrup urine disease patient WG-34.
Fisher CW; Lau KS; Fisher CR; Wynn RM; Cox RP; Chuang DT
Biochem Biophys Res Commun; 1991 Jan; 174(2):804-9. PubMed ID: 1847055
[TBL] [Abstract][Full Text] [Related]
10. Sequence of the E1 alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease.
Zhang B; Wappner RS; Brandt IK; Harris RA; Crabb DW
Am J Hum Genet; 1990 Apr; 46(4):843-6. PubMed ID: 2316528
[TBL] [Abstract][Full Text] [Related]
11. Molecular basis of maple syrup urine disease: novel mutations at the E1 alpha locus that impair E1(alpha 2 beta 2) assembly or decrease steady-state E1 alpha mRNA levels of branched-chain alpha-keto acid dehydrogenase complex.
Chuang JL; Fisher CR; Cox RP; Chuang DT
Am J Hum Genet; 1994 Aug; 55(2):297-304. PubMed ID: 8037208
[TBL] [Abstract][Full Text] [Related]
12. Maple syrup urine disease: mutation analysis in Turkish patients.
Dursun A; Henneke M; Ozgül K; Gartner J; Coşkun T; Tokatli A; Kalkanoğlu HS; Demirkol M; Wendel U; Ozalp I
J Inherit Metab Dis; 2002 May; 25(2):89-97. PubMed ID: 12118532
[TBL] [Abstract][Full Text] [Related]
13. [Gene analysis of maple syrup urine disease (MSUD)].
Mitsubuchi H; Nobukuni Y; Hayashida Y; Ohta K; Indo Y; Akaboshi I; Endo F; Matsuda I
Rinsho Byori; 1993 May; 41(5):484-91. PubMed ID: 8350511
[TBL] [Abstract][Full Text] [Related]
14. Maple syrup urine disease: it has come a long way.
Chuang DT
J Pediatr; 1998 Mar; 132(3 Pt 2):S17-23. PubMed ID: 9546032
[TBL] [Abstract][Full Text] [Related]
15. Molecular phenotypes in cultured maple syrup urine disease cells. Complete E1 alpha cDNA sequence and mRNA and subunit contents of the human branched chain alpha-keto acid dehydrogenase complex.
Fisher CW; Chuang JL; Griffin TA; Lau KS; Cox RP; Chuang DT
J Biol Chem; 1989 Feb; 264(6):3448-53. PubMed ID: 2914958
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the branched-chain alpha-ketoacid dehydrogenase and elucidation of a molecular basis for maple syrup urine disease.
Harris RA; Zhang B; Goodwin GW; Kuntz MJ; Shimomura Y; Rougraff P; Dexter P; Zhao Y; Gibson R; Crabb DW
Adv Enzyme Regul; 1990; 30():245-63. PubMed ID: 2403034
[TBL] [Abstract][Full Text] [Related]
17. A nonsense mutation (R242X) in the branched-chain alpha-keto acid dehydrogenase E1alpha subunit gene (BCKDHA) as a cause of maple syrup urine disease. Mutations in brief no. 160. Online.
Chinsky J; Appel M; Almashanu S; Costeas P; Ambulos N; Carmi R
Hum Mutat; 1998; 12(2):136. PubMed ID: 10694918
[TBL] [Abstract][Full Text] [Related]
18. Maple syrup urine disease due to a new large deletion at BCKDHA caused by non-homologous recombination.
Quental S; Martins E; Vilarinho L; Amorim A; João Prata M
J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S457-60. PubMed ID: 19085071
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of maple syrup urine disease using polymerase chain reaction-based mutation detection.
Silao CL; Padilla CD; Matsuo M
Pediatr Int; 2008 Jun; 50(3):312-4. PubMed ID: 18533943
[TBL] [Abstract][Full Text] [Related]
20. Premature termination of transcription and alternative splicing in the human transacylase (E2) gene of the branched-chain alpha-ketoacid dehydrogenase complex.
Lau KS; Lee J; Fisher CW; Cox RP; Chuang DT
FEBS Lett; 1991 Feb; 279(2):229-32. PubMed ID: 2001734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
